StockWatch
·
Specialty Chemicals
Quarterly ResultOct 26, 2026, 04:16 PM

Hawkins Reports Record Q2 Revenue of $313.8M, EPS $1.34

AI Summary

Hawkins, Inc. announced record-breaking financial results for its fiscal 2027 second quarter ended September 27, 2026. Revenue reached $313.8 million, a 12% increase year-over-year, driven by strong performance across all segments, particularly Water Treatment which saw a 16% rise. Diluted earnings per share (EPS) also hit a record at $1.34, up 23% from the prior year. The company also highlighted strategic growth through acquisitions, including Dave Symonds & Associates and Eagle Labs, expanding its presence in Florida and the Dallas-Fort Worth region.

Key Highlights

  • Hawkins reported record Q2 FY2027 revenue of $313.8M, up 12% YoY.
  • Record Q2 FY2027 diluted EPS of $1.34, up 23% YoY.
  • Record Q2 FY2027 net income of $27.8M, up 23% YoY.
  • Water Treatment segment revenue grew 16% to $175.0M.
  • Food & Health Sciences segment revenue grew 5% to $76.7M.
  • Industrial Solutions segment revenue grew 10% to $62.2M.
  • Acquired Dave Symonds & Associates and expanded into Dallas-Fort Worth via Eagle Labs acquisition.
  • Generated $75.5M operating cash flow and $53.1M free cash flow for the six months ended Sep 27, 2026.